Avidity Biosciences (NASDAQ:RNA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Avidity Biosciences (RNA) operate in?

Avidity Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Avidity Biosciences Stock (NASDAQ: RNA) stock price, news, charts, stock research, profile.

Open	$28.59
Close	$30.84
Volume / Avg.	1.38M / 1.20M
Day Range	$28.59 - $31.30
52 Wk Range	9.93 - 56.00
Market Cap	$3.65B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	16.4%
Days to Cover	11.07

Recent News

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic

William Blair starts coverage on Denali Therapeutics with an Outperform rating, citing its transport vehicle platform and promising therapies for neurodegenerative diseases.

Vandana Singh

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Avi Kapoor

Goldman Sachs Bullish On Avidity Biosciences, Cites Scalable RNA Therapeutics Platform For Rare Diseases

Goldman Sachs has initiated coverage on Avidity Biosciences with a Buy rating and a $59 price target, citing multi-blockbuster commercial opportunities for its RNA therapeutics in muscular dystrophies.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$28.59
Close	$30.84
Volume / Avg.	1.38M / 1.20M
Day Range	$28.59 - $31.30
52 Wk Range	9.93 - 56.00
Market Cap	$3.65B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	16.4%
Days to Cover	11.07

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Avidity Biosciences (RNA) stock?

You can purchase shares of Avidity Biosciences (NASDAQ:RNA) through any online brokerage.

View our list of the best stock brokerages

Who are Avidity Biosciences (RNA) competitors?

Other companies in Avidity Biosciences’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and SpringWorks Therapeutics (NASDAQ:SWTX).

What is the forecast, or price target, for Avidity Biosciences (RNA) stock?

Avidity Biosciences has a consensus price target of $58.60.

What is the current price for Avidity Biosciences (RNA)?

The stock price for Avidity Biosciences (NASDAQ: RNA) is $30.84 last updated January 21, 2025 at 5:08 PM EST.

Does Avidity Biosciences (RNA) pay a dividend?

There are no upcoming dividends for Avidity Biosciences.

When is Avidity Biosciences (NASDAQ:RNA) reporting earnings?

Avidity Biosciences’s Q4 earnings are confirmed for Wednesday, February 26, 2025.

Is Avidity Biosciences (RNA) going to split?

There is no upcoming split for Avidity Biosciences.

What sector and industry does Avidity Biosciences (RNA) operate in?

Avidity Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Avidity Biosciences

Avidity Biosciences (RNA) Forecast